28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-022395-31-ES (EUCTR)	13/06/2012	21/05/2012	A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bor ...	A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bor ...	AL Amyloidosis MedDRA version: 14.1;Level: HLGT;Classification code 10035227;Term: Plasma cell neopl ...	Trade Name: VELCADE INN or Proposed INN: BORTEZOMIB Other descriptive name: VELCADE Trade Name: Dexamet ...	E.M.N. - EUROPEAN MYELOMA NETWORK	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	110	Phase 3	United Kingdom;Germany;Netherlands;Denmark;Norway;France;Spain;Italy;Greece;Sweden

First Previous1Next Last